251 286 - Biotech Bayern

EpiGene GmbH
BIOTECH AGRO, FOOD, ENVIRONMENT
Keywords: Agrobiotechnology, Genomics
EpiGene GmbH, founded in 1999, is a genomics-based research and development
company focusing on applications in plant protection. The core competences
comprise the molecular characterization of plant-pathogen interactions
and the development of high throughput systems for molecular diagnostics
of involved genetic factors. In addition, research efforts include investigations of
the mode of action of plant protective agents at the molecular level and the
identification of mutations or differentially expressed genes in pathogens as
potential new targets.
EpiLogic GmbH
BIOTECH AGRO, FOOD, ENVIRONMENT
Keywords: Agrobiotechnology, Genomics
EpiLogic is a new European wide operating company involved in product
development based on genomic analysis of fungal pathogens propagated by
wind in agricultural crops (at present: cereals and vine). Pathogen analysis of
virulence and fungicide sensitivity are used as decision support for breeding,
choice of cultivar and fungicide management to ensure sustainable agriculture.
A genotype bank of several pathogens is currently being set up to offer high
quality inoculum for selection in laboratory, greenhouse and field. Additionally,
methods are under development for analysing and culturing new pathogens.
essex pharma GmbH
PHARMA & CHEMICAL INDUSTRY
Keywords: Drug Delivery
essex pharma is the German subsidiary of a multinational U.S.-based company,
leading in research of pharmaceutical and health care products with a strong
position in biotechnology. 2.2 billion US $ were spent on R&D in 2006. The most
prominent result in biotech is interferon alfa-2b for several anti-cancer and
anti-viral indications, later as pegylated interferon alfa-2b in hepatitis C. essex
pharma supplements its range by partnerships and licensing of new biotech
products, i.e. in immunology with infliximab, an immune modulating agent, for
the treatment of Crohn’s disease, colitis ulcerosa, spondylitis, rheumatoid and
psoriatic arthritis. Further innovative products for cardiovascular diseases and in
oncology, hepatology, allergology, dermatology and pulmology belong to the
portfolio.
Contact:
Dr. Friedrich G. Felsenstein
Hohenbachernstr. 19-21
D-85354 Freising
Phone: +49 (0) 8161 4990-80
Fax: +49 (0) 8161 4990-89
E-Mail: Friedrich.Felsenstein@EpiLogic.de
Internet: www.epigene.de
Contact:
Dr. Friedrich G. Felsenstein
Hohenbachernstr. 19-21
D-85354 Freising
Phone: +49 (0) 8161 4990-80
Fax: +49 (0) 8161 4990-89
E-Mail: Friedrich.Felsenstein@EpiLogic.de
Internet: www.EpiLogic.de
Contact:
Inge Bartel
Thomas-Dehler-Str. 27
D-81737 München
Phone: +49 (0) 89 62731-293
Fax: +49 (0) 89 62731-292
E-Mail: werner.weis@essex.de
Internet: www.essex.de
61